A detailed history of Vanguard Group Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Vanguard Group Inc holds 49,258,240 shares of ELAN stock, worth $898 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
49,258,240
Previous 49,468,637 0.43%
Holding current value
$898 Million
Previous $737 Million 8.8%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$14.37 - $16.46 $3.02 Million - $3.46 Million
-210,397 Reduced 0.43%
49,258,240 $802 Million
Q4 2023

Feb 14, 2024

BUY
$8.6 - $14.94 $4.02 Million - $6.98 Million
467,196 Added 0.95%
49,468,637 $737 Million
Q3 2023

Nov 14, 2023

BUY
$9.81 - $12.62 $3.55 Million - $4.57 Million
362,152 Added 0.74%
49,001,441 $551 Million
Q2 2023

Aug 14, 2023

BUY
$8.08 - $10.37 $18.7 Million - $24 Million
2,314,726 Added 5.0%
48,639,289 $489 Million
Q1 2023

May 15, 2023

BUY
$8.79 - $14.58 $5.56 Million - $9.23 Million
632,725 Added 1.38%
46,324,563 $435 Million
Q4 2022

Feb 10, 2023

BUY
$11.49 - $13.65 $34.6 Million - $41.2 Million
3,015,401 Added 7.07%
45,691,838 $558 Million
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $2.49 Million - $6.49 Million
200,259 Added 0.47%
42,676,437 $530 Million
Q2 2022

Aug 12, 2022

BUY
$19.63 - $26.62 $20.1 Million - $27.2 Million
1,023,648 Added 2.47%
42,476,178 $834 Million
Q1 2022

May 13, 2022

BUY
$24.65 - $29.0 $16 Million - $18.9 Million
650,715 Added 1.59%
41,452,530 $1.08 Billion
Q4 2021

Feb 14, 2022

SELL
$27.74 - $34.09 $1.62 Million - $2 Million
-58,573 Reduced 0.14%
40,801,815 $1.16 Billion
Q3 2021

Nov 12, 2021

SELL
$29.2 - $36.72 $48.4 Million - $60.9 Million
-1,658,702 Reduced 3.9%
40,860,388 $1.3 Billion
Q2 2021

Aug 13, 2021

BUY
$28.76 - $35.98 $1.22 Billion - $1.53 Billion
42,519,090 New
42,519,090 $1.47 Billion

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $8.64B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.